Related Experiment Video
Updated: Feb 8, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
PKM2 under hypoxic environment causes resistance to mTOR inhibitor in human castration resistant prostate cancer
Yota Yasumizu1, Hiroshi Hongo1, Takeo Kosaka1
1Department of Urology, Keio University School of Medicine, Tokyo, Japan.
Abstract:
The aim of this study was to explore the efficacy of mTOR inhibitor for castration-resistant prostate cancer (CRPC) under hypoxia. Although under normoxia C4-2AT6, it is a CRPC cell line, expressed elevated pAkt, pS6 and Pyruvate kinase M2 (PKM2) accompanied by elevated HIF-1a expression, 5% hypoxic condition further induced expression of these proteins. These results indicate hypoxic environment elevated PI3K/Akt/mTOR pathway in aggressive prostate cancer. However, C4-2AT6 cells treated with mTOR inhibitor under hypoxia less decreased compared to cells treated with the same dose drugs under normoxia. Western blot analysis showed mTOR inhibitor: RAD001 not only inhibited pS6, but also increased the expression of PKM2 in a dose and time dependent manner. Pyruvate kinase acts on glycolysis. PKM2, which is frequently express in tumor cells, is one isoform of pyruvate kinase. PKM2 is reported to act as a transcription factor. In the present study overexpression of PKM2 in C4-2AT6 induced resistance to RAD001 under normoxia. To evaluate the therapeutic effect of targeting PKM2, we inhibited PKM2 in C4-2AT6 under hypoxia using si-PKM2. The number of C4-2AT6 under chronic hypoxia exposed to siPKM2 significantly decreased compared to intact C4-2AT6 under chronic hypoxia. Furthermore, si-PKM2 improved resistance to mTOR inhibitor in C4-2AT6. When examined using clinical samples, high PKM2 expression was correlated with a high Gleason score and poor PSA free survival. These results suggested that up-regulation of PKM2 is one possibility of resistance to mTOR inhibitor in CRPC. And it is possible that PKM2 is a useful therapeutic target of CRPC.
Insights
Hypoxia increases resistance to mTOR inhibitors in castration-resistant prostate cancer (CRPC) by upregulating Pyruvate Kinase M2 (PKM2). Targeting PKM2 may overcome this resistance and improve therapeutic outcomes in CRPC patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Prostate cancer, particularly castration-resistant prostate cancer (CRPC), often exhibits elevated PI3K/Akt/mTOR pathway signaling.
- Hypoxia is a common feature in aggressive tumors and can influence treatment response.
- Pyruvate Kinase M2 (PKM2) is implicated in cancer cell metabolism and can act as a transcription factor.
Purpose of the Study:
- To investigate the efficacy of mTOR inhibitors in CRPC cells under hypoxic conditions.
- To explore the role of PKM2 in mediating resistance to mTOR inhibitors in CRPC.
- To evaluate PKM2 as a potential therapeutic target in CRPC.
Main Methods:
- Utilized C4-2AT6, a CRPC cell line, under normoxic and hypoxic (5%) conditions.
- Administered mTOR inhibitor (RAD001) and assessed protein expression via Western blot.
- Investigated the effect of PKM2 inhibition using si-PKM2 and analyzed clinical samples for PKM2 expression correlation.
Main Results:
- Hypoxia significantly upregulated pAkt, pS6, HIF-1a, and PKM2 in C4-2AT6 cells, enhancing PI3K/Akt/mTOR pathway activity.
- CRPC cells treated with mTOR inhibitor showed reduced sensitivity under hypoxia compared to normoxia.
- Overexpression of PKM2 conferred resistance to mTOR inhibition, while PKM2 inhibition sensitized cells to the mTOR inhibitor and reduced cell viability under hypoxia.
- High PKM2 expression in clinical samples correlated with higher Gleason scores and poorer PSA-free survival.
Conclusions:
- Upregulation of PKM2 is a mechanism contributing to mTOR inhibitor resistance in CRPC under hypoxic conditions.
- Targeting PKM2 presents a promising therapeutic strategy to overcome resistance and improve treatment efficacy in CRPC.
Related Concept Videos
Treatment Resistant Cancers
Resistivity
Resistance
Equivalent Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
Rolling Resistance
For instance, imagine a hard cylinder rolling on a comparatively soft surface. The cylinder's weight compresses the surface beneath it. As the cylinder moves, the material in front of it slows down due to...

